Elevated CEA and CA199 levels in NSCLC patients are indicative of intrapulmonary and distant metastases; elevated CEA, CYFRA 21-1 and CA199 levels in patients with NSCLC are indicative of lymphatic metastasis. Here, CEACAM5 is linked to Lymphatic Metastasis.